The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Unfavourable carcinoma of unknown primary (CUP) with gastrointestinal profile: A retrospective study.
 
Lorenzo Guidi
No Relationships to Disclose
 
Carmine Valenza
No Relationships to Disclose
 
Elena Battaiotto
No Relationships to Disclose
 
Luca Boscolo Bielo
No Relationships to Disclose
 
Edoardo Crimini
No Relationships to Disclose
 
Carmen Belli
No Relationships to Disclose
 
Lorenzo Gervaso
No Relationships to Disclose
 
Chiara Alessandra Cella
No Relationships to Disclose
 
Davide Ciardiello
No Relationships to Disclose
 
Konstantinos Venetis
No Relationships to Disclose
 
Luca Bottiglieri
No Relationships to Disclose
 
Mariacristina Ghioni
No Relationships to Disclose
 
Elena Guerini Rocco
No Relationships to Disclose
 
Nicola Fazio
No Relationships to Disclose
 
Maria Giulia Zampino
No Relationships to Disclose
 
Giuseppe Curigliano
Leadership - ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech